Erlotinib in lung cancer : impact and exceptional cases /

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Συρίγος, Κωνσταντίνος Νικ (Επιμελητής)
Μορφή: Βιβλίο
Γλώσσα:English
Έκδοση: Athens : Focus On Health, c2014.
Θέματα:

MARC

LEADER 00000nam a2200000 u 4500
001 4633
003 GR-PADA
005 20231031092544.0
008 150204s2014 en a|||e b GRE d
020 |a 9786188065529 
040 |a GrATPDL  |d ΕΘΝΙΚΗ ΣΧΟΛΗ ΔΗΜΟΣΙΑΣ ΥΓΕΙΑΣ-ΚΕΝΤΡΙΚΗ ΒΙΒΛΙΟΘΗΚΗ  |c ΠΑΝΕΠΙΣΤΗΜΙΟΥΠΟΛΗ ΑΘΗΝΩΝ 
041 0 |a eng 
082 |a 616.99424 
245 0 0 |a Erlotinib in lung cancer :  |b impact and exceptional cases /  |c editor Konstantinos N. Syrigos. 
260 |a Athens :   |b Focus On Health,  |c c2014. 
300 |a xxv, 360 σ. :  |b εικ. (ορισμένες έγχρ.) ;  |c 25 εκ. 
504 |a Περιέχει βιβλιογραφίες. 
650 0 |a Πνεύμονες  |x Καρκίνος  |x Θεραπεία.  |9 6306 
650 0 |a Lungs  |x Cancer  |x Treatment.  |9 6305 
700 1 |a Συρίγος, Κωνσταντίνος Νικ.  |e Επιμελητής  |9 6307 
942 |2 ddc  |c BK  |h 616.99424 ERL  |6 616_994240000000000_ERL 
952 |0 0  |1 0  |2 ddc  |4 0  |6 616_994240000000000_ERL  |7 1  |9 5129  |a MAIN  |b MAIN  |d 2020-01-10  |l 0  |o 616.99424 ERL  |p 00005156  |r 2020-01-10  |t 1  |w 2020-01-10  |y BK  |z Δωρεά Κωνσταντίνος Ν. Συρίγος 
952 |0 0  |1 0  |2 ddc  |4 0  |6 616_994240000000000_ERL  |7 0  |9 7435  |a MAIN  |b MAIN  |d 2020-01-10  |l 0  |o 616.99424 ERL  |p 00007660  |r 2023-10-31  |t 2  |w 2020-01-10  |y BK 
999 |c 5101  |d 5101 

Εγγραφή στο Ευρετήριο Αναζήτησης

_version_ 1784614218816815104
author2 Συρίγος, Κωνσταντίνος Νικ
author2_role Επιμελητής
author2_variant κ ν σ κν κνσ
author_facet Συρίγος, Κωνσταντίνος Νικ
author_sort Συρίγος, Κωνσταντίνος Νικ
building Campus Library III
collection LIB3 Catalog
dewey-full 616.99424
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 616 - Diseases
dewey-raw 616.99424
dewey-search 616.99424
dewey-sort 3616.99424
dewey-tens 610 - Medicine and health
format Book
fullrecord {"leader":"01351nam a2200253 u 4500","fields":[{"001":"4633"},{"003":"GR-PADA"},{"005":"20231031092544.0"},{"008":"150204s2014 en a|||e b GRE d"},{"020":{"subfields":[{"a":"9786188065529"}],"ind1":" ","ind2":" "}},{"040":{"subfields":[{"a":"GrATPDL"},{"d":"\u0395\u0398\u039d\u0399\u039a\u0397 \u03a3\u03a7\u039f\u039b\u0397 \u0394\u0397\u039c\u039f\u03a3\u0399\u0391\u03a3 \u03a5\u0393\u0395\u0399\u0391\u03a3-\u039a\u0395\u039d\u03a4\u03a1\u0399\u039a\u0397 \u0392\u0399\u0392\u039b\u0399\u039f\u0398\u0397\u039a\u0397"},{"c":"\u03a0\u0391\u039d\u0395\u03a0\u0399\u03a3\u03a4\u0397\u039c\u0399\u039f\u03a5\u03a0\u039f\u039b\u0397 \u0391\u0398\u0397\u039d\u03a9\u039d"}],"ind1":" ","ind2":" "}},{"041":{"subfields":[{"a":"eng"}],"ind1":"0","ind2":" "}},{"082":{"subfields":[{"a":"616.99424"}],"ind1":" ","ind2":" "}},{"245":{"subfields":[{"a":"Erlotinib in lung cancer :"},{"b":"impact and exceptional cases /"},{"c":"editor Konstantinos N. Syrigos."}],"ind1":"0","ind2":"0"}},{"260":{"subfields":[{"a":"Athens : "},{"b":"Focus On Health,"},{"c":"c2014."}],"ind1":" ","ind2":" "}},{"300":{"subfields":[{"a":"xxv, 360 \u03c3. :"},{"b":"\u03b5\u03b9\u03ba. (\u03bf\u03c1\u03b9\u03c3\u03bc\u03ad\u03bd\u03b5\u03c2 \u03ad\u03b3\u03c7\u03c1.) ;"},{"c":"25 \u03b5\u03ba."}],"ind1":" ","ind2":" "}},{"504":{"subfields":[{"a":"\u03a0\u03b5\u03c1\u03b9\u03ad\u03c7\u03b5\u03b9 \u03b2\u03b9\u03b2\u03bb\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03af\u03b5\u03c2."}],"ind1":" ","ind2":" "}},{"650":{"subfields":[{"a":"\u03a0\u03bd\u03b5\u03cd\u03bc\u03bf\u03bd\u03b5\u03c2"},{"x":"\u039a\u03b1\u03c1\u03ba\u03af\u03bd\u03bf\u03c2"},{"x":"\u0398\u03b5\u03c1\u03b1\u03c0\u03b5\u03af\u03b1."},{"9":"6306"}],"ind1":" ","ind2":"0"}},{"650":{"subfields":[{"a":"Lungs"},{"x":"Cancer"},{"x":"Treatment."},{"9":"6305"}],"ind1":" ","ind2":"0"}},{"700":{"subfields":[{"a":"\u03a3\u03c5\u03c1\u03af\u03b3\u03bf\u03c2, \u039a\u03c9\u03bd\u03c3\u03c4\u03b1\u03bd\u03c4\u03af\u03bd\u03bf\u03c2 \u039d\u03b9\u03ba."},{"e":"\u0395\u03c0\u03b9\u03bc\u03b5\u03bb\u03b7\u03c4\u03ae\u03c2"},{"9":"6307"}],"ind1":"1","ind2":" "}},{"942":{"subfields":[{"2":"ddc"},{"c":"BK"},{"h":"616.99424 ERL"},{"6":"616_994240000000000_ERL"}],"ind1":" ","ind2":" "}},{"952":{"subfields":[{"0":"0"},{"1":"0"},{"2":"ddc"},{"4":"0"},{"6":"616_994240000000000_ERL"},{"7":"1"},{"9":"5129"},{"a":"MAIN"},{"b":"MAIN"},{"d":"2020-01-10"},{"l":"0"},{"o":"616.99424 ERL"},{"p":"00005156"},{"r":"2020-01-10"},{"t":"1"},{"w":"2020-01-10"},{"y":"BK"},{"z":"\u0394\u03c9\u03c1\u03b5\u03ac \u039a\u03c9\u03bd\u03c3\u03c4\u03b1\u03bd\u03c4\u03af\u03bd\u03bf\u03c2 \u039d. \u03a3\u03c5\u03c1\u03af\u03b3\u03bf\u03c2"}],"ind1":" ","ind2":" "}},{"952":{"subfields":[{"0":"0"},{"1":"0"},{"2":"ddc"},{"4":"0"},{"6":"616_994240000000000_ERL"},{"7":"0"},{"9":"7435"},{"a":"MAIN"},{"b":"MAIN"},{"d":"2020-01-10"},{"l":"0"},{"o":"616.99424 ERL"},{"p":"00007660"},{"r":"2023-10-31"},{"t":"2"},{"w":"2020-01-10"},{"y":"BK"}],"ind1":" ","ind2":" "}},{"999":{"subfields":[{"c":"5101"},{"d":"5101"}],"ind1":" ","ind2":" "}}]}
id lib3_5101
illustrated Illustrated
institution University of West Attica
isbn 9786188065529
language English
physical xxv, 360 σ. : εικ. (ορισμένες έγχρ.) ; 25 εκ.
publishDate 2014
publisher Focus On Health,
record_format marc
spelling Erlotinib in lung cancer : impact and exceptional cases / editor Konstantinos N. Syrigos.
Athens : Focus On Health, c2014.
xxv, 360 σ. : εικ. (ορισμένες έγχρ.) ; 25 εκ.
Περιέχει βιβλιογραφίες.
Πνεύμονες Καρκίνος Θεραπεία. 6306
Lungs Cancer Treatment. 6305
Συρίγος, Κωνσταντίνος Νικ. Επιμελητής 6307
spellingShingle Erlotinib in lung cancer : impact and exceptional cases /
Πνεύμονες Καρκίνος Θεραπεία. 6306
Lungs Cancer Treatment. 6305
title Erlotinib in lung cancer : impact and exceptional cases /
title_auth Erlotinib in lung cancer : impact and exceptional cases /
title_full Erlotinib in lung cancer : impact and exceptional cases / editor Konstantinos N. Syrigos.
title_fullStr Erlotinib in lung cancer : impact and exceptional cases / editor Konstantinos N. Syrigos.
title_full_unstemmed Erlotinib in lung cancer : impact and exceptional cases / editor Konstantinos N. Syrigos.
title_short Erlotinib in lung cancer :
title_sort erlotinib in lung cancer impact and exceptional cases
title_sub impact and exceptional cases /
topic Πνεύμονες Καρκίνος Θεραπεία. 6306
Lungs Cancer Treatment. 6305
topic_facet Πνεύμονες
Lungs
Καρκίνος
Θεραπεία.
Cancer
Treatment.
work_keys_str_mv AT syrigoskōnstantinosnik erlotinibinlungcancerimpactandexceptionalcases